Filing Details
- Accession Number:
- 0001079973-11-000994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-15 14:35:36
- Reporting Period:
- 2011-12-13
- Filing Date:
- 2011-12-15
- Accepted Time:
- 2011-12-15 14:35:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1167419 | Aspenbio Pharma Inc. | APPY | In Vitro & In Vivo Diagnostic Substances (2835) | 841553387 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187604 | Jeffrey Mcgonegal | C/O Aspenbio Pharma, Inc. 1585 S. Perry Street Castle Rock CO 80104 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-12-13 | 3,625 | $1.58 | 48,431 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,000 | Indirect | By IRA |
Common Stock | 300 | Indirect | By child |